Replies to post #38696 on Relief Therapeutics Holding AG (RLFTF)

[go_wamu]

... but if they don't, it's their fault if they both go under !
... and it will be so if they keep accusing themselves !
1) NeuroRx together with its investor Big Rock Partners Acquisition.
2) Relief because they lose valuable time in working with new European partners
... but remember: Aviptadil is the tell and Relief owns the patents !

[elllk]

I am going to speculate on this issue for a moment. I think NeuroRx has a lot of the data analyzed and it is showing very good things but they don't have all of it done (possibly important issues about lung radiographs and x-rays, etc.). Is it not the case that if they gave what they have to Relief it would be substantial enough that Relief would have to release it. NeuroRx is not obligated to release the data they have. They may want all the data in place and fully analyzed before it is released. They may feel that even with very good data in place the full and comprehensive analysis will be even better. NeuroRx may also want to be further along in establishing how things are going to be worked out for the various partners in this venture. Having all of these things in much better shape (i.e. a NASDAQ listing, etc.) would allow a much better stock market response to the announcement of an EUA.

The controversy over the lousy $4M may be cover for Relief and NeuroRx to fight a bit over leverage on how several of these things ultimately get worked out.